Sentence examples for mouse bacteremia model from inspiring English sources

Moreover, LACΔhlgABC had modestly reduced ability to cause mortality in a mouse bacteremia model.

To test protective efficacy of rabbit immune serum, we employed a modified mouse bacteremia model developed previously in our laboratory [42], [43], [44].

Having demonstrated that diheteroglycan-specific antibodies are opsonic to E. faecalis CPS-C and CPS-D strains, we assessed in vivo protection by passive immunization in a mouse bacteremia model.

On the other hand, the ΔhlgABC strain caused moderately reduced mortality compared with the wild-type strain in the mouse bacteremia model at all times 36 h post-infection (for up to 192 h), albeit the difference was significant only at 72 h (Fig. 7B).

To approach conditions encountered by these bacteria during human infections, further studies were performed during exposure to urine, in a peritonitis mouse model and in a mouse bacteremia mouse model thus leading to the identification of new genetic determinants putatively involved in the pathogenic potential of Enterococcus faecalis.

Recent unpublished data from Magnus Hook's lab (U. Texas A and M) demonstrate that a L. lactis ClfA-expressing strain is capable of killing mice in a mouse bacteremia survival model (data not shown).

In a mouse meningococcal bacteremia model the role of TLR9 in preventing bacteremia was also confirmed.

Two R-IVET systems with different levels of sensitivity have been constructed in a E. faecalis V583 derivative strain and tested in the insect model Galleria mellonella, during growth in urine, in a mouse bacteremia and in a mouse peritonitis model.

Nonetheless, mice inoculated with LACΔhlgABC had on average 20% increased survival in the bacteremia model compared with mice infected with the LAC wild-type strain, and the mutant strain had reduced survival in human blood (Fig. 7B and C).

Using highly sensitive in vivo competition assays, ACME was shown to confer bacterial survival advantage in a rabbit bacteremia model and a mouse gastrointestinal colonization model [5], [10].

In vivo efficacy was demonstrated in a murine bacteremia model with a colistin-resistant P. aeruginosa clinical isolate.